CDC issues warning, updated recommendations for blood disorder drug
The Centers for Disease Control and Prevention recently issued updated recommendations to prevent meningococcal disease in patients who are prescribed eculizumab, a drug used to treat two rare blood disorders. CDC recommends health care providers consider antimicrobial prophylaxis for the duration of eculizumab therapy; administer meningococcal vaccine two weeks prior to the first dose of the drug; and maintain a high index of suspicion for meningococcal disease in patients who present with symptoms.
Related News Articles
Headline
The National Collaborative for Improving the Clinical Learning Environment this week released guidance to help health care system leaders work with clinical…
Headline
More than 704,000 people arrived alive at a hospital emergency department for treatment of a firearm-related injury between 2006 and 2014, resulting in an…
Headline
The Centers for Medicare & Medicaid Services should continue to work with national standards body X12 to include the new unique device identifier on its…
Headline
The Centers for Disease Control and Prevention today issued recommendations to help health care providers and laboratories prevent the spread of Candida auris…
Headline
An estimated 92% of hospital workers report receiving a flu vaccine for the 2016-17 flu season, compared with 76% of ambulatory care workers and 68% of long-…
Headline
More than 2 million cases of chlamydia, gonorrhea and syphilis were reported in the U.S. in 2016, a record high, according to the latest annual report by the…